186 results
Page 3 of 10
8-K
EX-4.1
ivzs1cipnk 5qvue0p
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
c9c1kz0
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-4.2
vc3ibk ev
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-4.1
bzzg2e vkk6r
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
424B3
bqvympy v761v
30 Dec 19
Prospectus supplement
10:07am
8-K
EX-4.1
hy6y2o70kiudb
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-4.2
x35aju 0va
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
424B5
419gf1gk6cu5b3
13 Dec 19
Prospectus supplement for primary offering
7:59am
424B4
3tfp3my1n eux95q
15 Nov 19
Prospectus supplement with pricing info
12:00am
8-K
EX-4.3
adqsc
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.1
j27n7a27
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.4
8ojki7za 36cq4i2xaiv
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.2
55jzj
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm